Carvana drops despite higher sales
Wall Street Breakfast
00:00
Moderna FDA reverses review refusal
Julie Morgan explains the FDA's acceptance of Moderna's mRNA-1010 BLA and the assigned August 5 action date.
Play episode from 02:19
Transcript
Julie Morgan explains the FDA's acceptance of Moderna's mRNA-1010 BLA and the assigned August 5 action date.
